Key result
Single-dose rectal sodium polystyrene sulfonate is linked to necrotic small bowel ischaemia requiring resection.
Why the study?
Sodium polystyrene sulfonate (SPS) use has been linked to intestinal ulceration and necrosis, but its role in small bowel ischaemia after cardiac surgery is rarely described.
Case Report (n=1)
No
Routine rectal administration of sodium polystyrene sulfonate (SPS) should be avoided in vulnerable post-cardiac surgery patients due to the risk of severe gastrointestinal injury, including histologically confirmed small bowel ischemia.
May warrant caution with rectal sodium polystyrene sulfonate post-cardiac surgery; hypothesis-generating for causality and incidence of ischaemic complications.
Ischaemic bowel remains one of the most serious complications following cardiac surgery, with mortality rates reaching up to 70%. Sodium polystyrene sulfonate (SPS), particularly when administered with sorbitol, has been linked to intestinal ulceration and necrosis, especially in patients with renal impairment. We describe a rare case of small bowel ischaemia attributed to SPS use in a 72-year-old woman with chronic kidney disease who underwent redo double valve replacement with septal myectomy. Her postoperative course was complicated by acute kidney injury and hyperkalaemia, for which a single dose of rectal SPS was administered. Within hours, she developed severe abdominal pain and raised lactate levels. Computed tomographic mesenteric angiography revealed pneumatosis intestinalis and portal venous gas. Emergency laparotomy identified a 5-cm segment of necrotic small bowel, which was resected. Histopathology confirmed diffuse ischaemic changes with kayexalate crystals embedded in the bowel wall, establishing a causal link to SPS. The patient’s recovery was protracted and complicated by stroke and pneumonia, but she was ultimately discharged in stable condition. This case highlights a rare, clinically important postoperative hazard and supports avoiding routine rectal SPS in vulnerable cardiac surgical patients. SPS-associated gastrointestinal injury after cardiac surgery can mimic postoperative mesenteric ischaemia and may involve the small bowel, not only the colon. Temporal onset after SPS exposure and kayexalate crystals within the injured bowel support SPS as a proximate contributor, but patient-specific low-flow and comorbidity factors must also be acknowledged. In high-risk post-cardiac surgery patients, treat hyperkalaemia with rapid temporising therapies and early CKRT or dialysis; reserve SPS for selected non-emergent situations and maintain a low threshold for CT imaging and surgical review.
No takes yet. Share an insight, caveat, or question.
Lizwan et al. (2026) conducted a case report in Hyperkalaemia post cardiac surgery (n=1). Sodium polystyrene sulfonate (SPS) was evaluated on Small bowel ischaemia. Administration of a single 15 g rectal dose of sodium polystyrene sulfonate for postoperative hyperkalaemia was associated with histologically confirmed necrotic small bowel ischaemia requiring resection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: